COVID-19 Serologic Strategies for Skilled Nursing Facilities

Not Applicable

Completed

• Conditions: COVID-19
• Interventions: Other: Cohorting

• Registration Number: NCT05270980
• Lead Sponsor: NYU Langone Health

Brief Summary

The COVID-19 pandemic ravaged United States skilled-nursing facilities (SNFs). Novel strategies that maximize the safety and quality of life for SNF residents with ADRD and staff who care for them are urgently needed. Thus, the study's objectives are:

1. To rapidly plan and pilot test an intervention that leverages COVID-19 antibody and PCR status to pair SNF staff with residents in the safest way possible

2. To reduce reduced COVID-19 incidence rate compared to SNFs not using this novel staff-resident assignment strategy.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-08-11
• Primary Completion: 2022-02-04
• Study Completion: 2022-02-04
• Study First Submitted: 2022-03-07
• Study First Submitted QC: 2022-03-07
• Study First Posted: 2022-03-08
• Results First Submitted: 2023-02-07
• Status Verified: 2023-03
• Results First Submitted QC: 2023-03-09
• Last Update Submitted: 2023-03-09
• Results First Posted: 2023-04-06
• Last Update Posted: 2023-04-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 87

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention Group (Cohorting)	Cohorting	-

Primary Outcome Measures

Name	Time	Method
Number of New COVID-19 Detected Infections Among Residents	Up to Month 5

Secondary Outcome Measures

Name	Time	Method
Number of New COVID-19 Detected Infections Among Staff	Up to Month 5
Number of Hospitalizations Over Time	Up to Month 5

Trial Locations

Locations (2)

ArchCare at Mary Manning Walsh Home (MMW); 🇺🇸 New York, New York, United States

ArchCare at Terence Cardinal Cooke Health Care Center (TCC); 🇺🇸 New York, New York, United States